Incivek Sales Data
| Rank 68 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Incivek U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 68 ( 18) |
$234,084 | -12.08% | 14 | -12.50% |
| Q4 2012 | 50 (5) |
$266,240 | -9.14% | 16 | -11.11% |
| Q3 2012 | 45 (5) |
$293,018 | -18.72% | 18 | -18.18% |
| Q2 2012 | 40 ( 2) |
$360,525 | -2.91% | 22 | -8.33% |
| Q1 2012 | 42 (13) |
$371,349 | -16.88% | 24 | -17.24% |
| Q4 2011 | 29 (11) |
$446,754 | 33.13% | 29 | 31.82% |
| Q3 2011 | 40 ( ) |
$335,582 |  |
22 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| June 22, 2011 | New Drug Effectively Treats Hepatitis C |
| May 23, 2011 | FDA Approves Incivek to Fight Hepatitis C |
| May 23, 2011 | Incivek Approved for Hepatitis C |
